Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.
Where this comes from
- Record sourced from PubMed, PMID 29340562.
- Also identified by DOI 10.1001/jamainternmed.2017.8016 and PMC identifier 5876838.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses Medicare Part D drug utilization and spending data to estimate potential Part D program and beneficiary savings on brand-name medications excluded by pharmacy benefit managers for which generic substitutes are available.
Medical subject headings
- Cost Savings
- Drug Substitution
- Drugs, Generic
- Health Expenditures
- Medicare Part D